A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin

Clinical trial NCT04662164 · WITHDRAWN

Trial details

NCT number: NCT04662164
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Patients

Start date: 2025-12-01
Primary completion: 2025-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.